Germany Ready to Step On The Gas For Medtech But Reimbursement Delays Still Block The Road
Executive Summary
After very complex national elections in 2017, Jens Spahn (CDU) emerged from the confusion holding the health portfolio. He is now ready to broach the trickier elements of his role, including finding solutions for the currently lengthy reimbursement delays for innovative medtech, which is a top priority for local manufacturers.
You may also be interested in...
Germany’s Digital Health Fast-Track Scheme: What Manufacturers Need To Know
Understanding the German reimbursement system is crucial for any medtech firm eyeing the European market, and healthtech innovators in particular may benefit from its fast-track digital health app scheme. But how does the scheme work, and who can apply?
New Digital Strategy For Germany, But Health Care Is Still Playing Catch-up
A renewed attempt by Germany to press its digital leadership credentials has drawn a muted reaction in health care circles.
German Health-Care Policymaking Back On Track As Coalition Comes Together
Germany's center-left SPD party will be the junior partner in the new government after 66% of party members voted in favor of another coalition with the center-right Christian Union parties led by Angela Merkela. Jens Spahn, who is in Merkel's party but not in her inner circle, has already been given the health portfolio.